Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound

被引:21
作者
Tardif, Jean-Claude [1 ]
Gregoire, Jean
L'Allier, Philippe L.
Ibrahim, Reda
Lavoie, Marc-Andre
LeMay, Michel
Cohen, Eric
Levesque, Sylvie
Keller, Pierre-Frederic
Heinonen, Therese
Guertin, Marie-Claude
机构
[1] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Res Ctr, Montreal Heart Inst, Montreal, PQ H3C 3J7, Canada
[3] Montreal Heart Inst, Coordinating Ctr, Montreal, PQ H1T 1C8, Canada
[4] Ottawa Heart Inst, Ottawa, ON, Canada
[5] Sunnybrook & Womens Hosp, Toronto, ON, Canada
关键词
D O I
10.1016/j.amjcard.2006.01.052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We assessed vascular changes during atherosclerosis regression. Compensatory enlargement of coronary arteries accommodates plaque burden during atherosclerosis development. Lipid-lowering therapy has altered the natural history of coronary atherosclerosis, but the arterial changes that occur during disease regression need to be clarified. Intravascular ultrasound was performed at baseline and after similar to 18 months in 432 patients with coronary disease. Mean plaque, lumen, and total vessel area were computed in a 30-mm coronary segment of interest. Mean low-density lipoprotein cholesterol level was 2.4 mmol/L, and 88% of patients received statins. Overall, changes in plaque and total vessel areas were highly correlated (r = 0.82, p < 0.0001). Among the 227 patients with plaque regression, the plaque area decrease was -0.58 +/- 0.54 mm(2), and changes in total vessel and lumen areas were -1.02 +/- 1.10 and -0.44 +/- 0.86 mm, respectively. The decrease in plaque area correlated better with the change in total vessel area (r = 0.64, p < 0.0001) than with the change in lumen area (r = 0.20, p = 0.003). The relation between plaque regression and decrease in total vessel area was significantly better (p = 0.019) for patients with a > 40% atheroma area (r = 0.72; p < 0.0001) than for those with <= 40% (r = 0.48; p = 0.0004). In conclusion, regression of atherosclerotic plaque is generally accompanied by a decrease in total vessel size, without an increase in luminal dimensions. This reverse vascular remodeling may be responsible for the "regression paradox," whereby secondary prevention is associated with clinical benefits despite minimal improvement in coronary lumen dimensions. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:23 / 27
页数:5
相关论文
共 25 条
[1]   ATHEROSCLEROSIS OF THE AORTA AND CORONARY-ARTERIES AND CARDIOVASCULAR RISK-FACTORS IN PERSONS AGED 6 TO 30 YEARS AND STUDIED AT NECROPSY (THE BOGALUSA HEART-STUDY) [J].
BERENSON, GS ;
WATTIGNEY, WA ;
TRACY, RE ;
NEWMAN, WP ;
SRINIVASAN, SR ;
WEBBER, LS ;
DALFERES, ER ;
STRONG, JP .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (09) :851-858
[2]   REGRESSION OF CORONARY-ARTERY DISEASE AS A RESULT OF INTENSIVE LIPID-LOWERING THERAPY IN MEN WITH HIGH-LEVELS OF APOLIPOPROTEIN-B [J].
BROWN, G ;
ALBERS, JJ ;
FISHER, LD ;
SCHAEFER, SM ;
LIN, JT ;
KAPLAN, C ;
ZHAO, XQ ;
BISSON, BD ;
FITZPATRICK, VF ;
DODGE, HT .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) :1289-1298
[3]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[4]   Effects of lipid-lowering by simvastatin on human atherosclerotic lesions - A longitudinal study by high-resolution, noninvasive magnetic resonance imaging [J].
Corti, R ;
Fayad, ZA ;
Fuster, V ;
Worthley, SG ;
Helft, G ;
Chesebro, J ;
Mercuri, M ;
Badimon, JJ .
CIRCULATION, 2001, 104 (03) :249-252
[5]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[6]   COMPENSATORY ENLARGEMENT OF HUMAN ATHEROSCLEROTIC CORONARY-ARTERIES [J].
GLAGOV, S ;
WEISENBERG, E ;
ZARINS, CK ;
STANKUNAVICIUS, R ;
KOLETTIS, GJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (22) :1371-1375
[7]   Intravascular ultrasound assessment of atherosclerosis [J].
Guédès A. ;
Tardif J.-C. .
Current Atherosclerosis Reports, 2004, 6 (3) :219-224
[8]   Regression of coronary atherosclerosis by simvastatin - A serial intravascular ultrasound study [J].
Jensen, LO ;
Thayssen, P ;
Pedersen, KE ;
Stender, S ;
Haghfelt, T .
CIRCULATION, 2004, 110 (03) :265-270
[9]   Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis - A randomized controlled trial [J].
Nissen, SE ;
Tuzcu, EM ;
Schoenhagen, P ;
Brown, BG ;
Ganz, P ;
Vogel, RA ;
Crowe, T ;
Howard, G ;
Cooper, CJ ;
Brodie, B ;
Grines, CL ;
DeMaria, AN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (09) :1071-1080
[10]   Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes - A randomized controlled trial [J].
Nissen, SE ;
Tsunoda, T ;
Tuzcu, EM ;
Schoenhagen, P ;
Cooper, CJ ;
Yasin, M ;
Eaton, GM ;
Lauer, MA ;
Sheldon, WS ;
Grines, CL ;
Halpern, S ;
Crowe, T ;
Blankenship, JC ;
Kerensky, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (17) :2292-2300